The global demand for In Vitro Toxicity Testing Market is presumed to reach the market size of nearly USD 23.78 MN by 2028 from USD 11.24 MN in 2021 with a CAGR of 11.3% under the study period 2022 - 2028.
In vitro toxicity testing is a research-based evaluation of the effects of toxic chemicals on cultured bacteria or mammalian cells. In vitro studies (i.e., in glass) are performed against microorganisms, cells, or biological molecules outside of normal biological conditions. When testing a drug in vitro, the concentration of the drug is limited to a known volume. This is critical because all drug behaviour assessments are essentially demonstrated at defined proportions. This is primarily done to assess the safety of drug development and chemical strength. The goal of toxicity testing is to develop data that can adequately protect public health from the adverse effects of exposure to environmental factors.
Market Dynamics
The growth in technological advancement to evaluate drug safety, the upsurge in consumer goods safety, the increase in ranking and screening of potential drugs, and the rise in the number of in-vitro tests conducted are key industry drivers for in-vitro toxicology testing. In addition, increased investment in research and development and opposition to animal testing prompted in-vitro toxicology testing. However, the government's stringent regulations and a lack of professionals are significant barriers to in-vitro testing.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro toxicity testing. The growth and trends of in vitro toxicity testing industry provide a holistic approach to this study.
Market Segmentation
This section of the in vitro toxicity testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product & Service
- Covid Impact
- Consumables
- Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, Other Assays)
- Equipment
- Software
- Services
By Method
- Cellular Assays
- Biochemical Assays
- In Silico Models
- Ex Vivo Models
By Toxicity Endpoint & Test
- ADME
- Skin Irritation, Corrosion, & Sensitization
- Genotoxicity Testing
- Cytotoxicity Testing
- Ocular Toxicity
- Organ Toxicity
- Phototoxicity Testing
- Dermal Toxicity
- Other Toxicity Endpoints & Tests
By Industry
- Covid Impact
- Pharmaceuticals & Biopharmaceuticals
- Cosmetic & Household Products
- Food
- Chemicals
By Technology
- Cell Culture Technologies
- High-Throughput Technologies
- Toxicogenomics
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the In Vitro Toxicity Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global In Vitro Toxicity Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in vitro toxicity testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
